On January 5, 1921, Swiss author and dramatist Friedrich Dürrenmatt was born. Dürrenmatt was a proponent of epic theatre whose plays reflected the recent experiences of World War II. The politically active author ‘s work included avant-garde dramas, philosophical crime novels, and macabre satire. Especially his play “The Physicists” ( 1961 ) deals with questions of scientific ethics and humanity ‘s ability to handle its intellectual responsibilities.
“A story is not finished, until it has taken the worst turn.” (Friedrich Dürrenmatt)
Friedrich Dürrenmatt was born in Konolfingen, a small town about thirteen miles from Bern in the Emmental in Switzerland, the son of a Protestant pastor. The family moved to Bern in 1935. Dürrenmatt began studies in philosophy, German language and literature at the University of Zurich in 1941, but moved to the University of Bern after one semester. It was here that he first became interested in playwriting after becoming a regular patron of the operettas. Among his favorite playwrights were Aristophanes and Thornton Wilder.[3] In December 1943 he was on the point of transferring from the University of Zürich to the University of Bern, where he intended to write a doctoral dissertation on “Kierkegaard and the Tragic ”, when he suddenly decided to turn to writing as a career and dropped his academic career. In 1945–46, he wrote his first play It is Written, which premiered to great controversy.
A massive new survey developed by MIT researchers reveals some distinct global preferences concerning the ethics of autonomous vehicles, as well as some regional variations in those preferences.
The survey has global reach and a unique scale, with over 2 million online participants from over 200 countries weighing in on versions of a classic ethical conundrum, the “Trolley Problem.” The problem involves scenarios in which an accident involving a vehicle is imminent, and the vehicle must opt for one of two potentially fatal options. In the case of driverless cars, that might mean swerving toward a couple of people, rather than a large group of bystanders.
“The study is basically trying to understand the kinds of moral decisions that driverless cars might have to resort to,” says Edmond Awad, a postdoc at the MIT Media Lab and lead author of a new paper outlining the results of the project. “We don’t know yet how they should do that.”
This working document constitutes a draft of the AI Ethics Guidelines produced by the European Commission’s High-Level Expert Group on Artificial Intelligence (AI HLEG), of which a final version is due in March 2019.
Earlier posts in Lifeboat followed this research… From what I understand, Italy decided to no longer host the surgery because of opposition by ethics committees, not his research or methods.
Disabled Valery Spiridonov, 33, was ready to have his neck severed by Professor Sergio Canavero — dubbed ‘Dr Frankenstein’ — and his head reattached to a new, healthy body.
Supersonic air travel is back. 15 years after the Concorde was grounded, everyone from aerospace companies to NASA to small startups is working to bring back ultrafast civilian aircraft. We take a look at the engineering challenges that make supersonic flight so difficult, and try to figure out what’s different about this new generation of planes.
The Verge’s sponsors play an important role in funding our journalism, but do not influence editorial content. For more information about our ethics policy, visit https://www.theverge.com/ethics-statement.
Not sure if this is real or still vaporware yet. But it IS inevitable. It’s not a matter of “if”, but “when”. And we’re most likely not going to be able to regulate it much, either. If an embryo or fetus is not a human, then parents have the right to do anything they want to it. You might think that this is going to result in eugenics, like erasing melanin genes and starting a race against the fictitious “white genocide”. You’re right. But if you think that’s as bad as it’ll get, think more creatively. What happens when poor parents get paid to implant “willing servility” genes into their unborn children, in order to pay bills. The future is now. Cyborgs will not destroy humanity, but humanity itself might. What kinds of rights can be written into law to prevent this kind of extortion, that won’t also grant fetal personhood and end up derailing abortion rights? It’s going to be a bumpy ride, folks, buckle up!
A Chinese researcher claims he helped make the world’s first genetically edited babies — twin girls born this month, and with DNA he says he altered with a powerful new tool capable of rewriting the very blueprint of life.
If true, it would be a profound leap of science and ethics.
A U.S. scientist said he took part in the work in China, but this kind of gene editing is banned in the United States because the DNA changes can pass to future generations and risks harming other genes.
HONG KONG (AP) — A Chinese researcher claims that he helped make the world’s first genetically edited babies — twin girls born this month whose DNA he said he altered with a powerful new tool capable of rewriting the very blueprint of life. If true, it would be a profound leap of science and ethics. A U.S. scientist said he took part in the work in China, but this kind of gene editing is banned in the United States because the DNA changes can pass to future generations and it risks harming other genes. Many mainstream scientists think it’s too unsafe to try, and some denounced the Chinese report as human experimentation.
Michael B. Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) was a professor of clinical medicine at Michigan State University and is the author of several books on aging, who is best known for his views on telomerase therapy as a possible treatment for cellular senescence. Fossel has appeared on many major news programs to discuss aging and has appeared regularly on National Public Radio (NPR). He is also a respected lecturer, author, and the founder and former editor-in-chief of the Journal of Anti-Aging Medicine (now known as Rejuvenation Research).
Prior to earning his M.D. at Stanford Medical School, Fossel earned a joint B.A. (cum laude) and M.A. in psychology at Wesleyan University and a Ph.D. in neurobiology at Stanford University. He is also a graduate of Phillips Exeter Academy. Prior to graduating from medical school in 1981, he was awarded a National Science Foundation fellowship and taught at Stanford University.
In addition to his position at Michigan State University, Fossel has lectured at the National Institute for Health, the Smithsonian Institution, and at various other universities and institutes in various parts of the world. Fossel served on the board of directors for the American Aging Association and was their executive director.
Fossel has written numerous articles on aging and ethics for the Journal of the American Medical Association and In Vivo, and his first book, entitled Reversing Human Aging was published in 1996. The book garnered favorable reviews from mainstream newspapers as well as Scientific American and was published in six languages. A magisterial academic textbook on by Fossel entitled Cells, Aging, and Human Disease was published in 2004 by Oxford University Press.
Since his days as a teacher at Stanford University, Fossel has studied aging from a medical and scientific perspective with a particular emphasis on premature aging syndromes such as progeria, and since at least 1996 he has been a strong and vocal advocate of [telomerase therapy]] as a potential treatment of age-related diseases, disorders, and syndromes such as progeria, Alzheimer’s disease, atherosclerosis, osteoporosis, cancer, and other conditions. However, he is careful to qualify his advocacy of telomerase therapy as being a potential treatment for these conditions rather than a “cure for old age” and a panacea for age-related medical conditions, albeit a potential treatment that could radically extend the maximum human life span and reverse the aging process in most people. Specifically, Fossel sees the potential of telomerase therapy as being the single most effective point of intervention in a wide variety of age-related medical conditions. His new book, The Telomerase Revolution, (BenBella, 2015) gives a careful explanation of aging, age-related diseases, and the prospects for intervention, including upcoming human trials.
Under what circumstances should militaries delegate the decision to take a human life to machines? It’s a moral leap that the international community is grappling with.
